Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention

NCT01757457 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Intracoronary administration of an abciximab bolus during primary PCI
DRUG: Intravenous administration of an abciximab bolus during primary PCI

Sponsor

Azienda Ospedaliero Universitaria Maggiore della Carita